TW200716123A - Pteridines useful as HCV inhibitors and methods for the preparation thereof - Google Patents

Pteridines useful as HCV inhibitors and methods for the preparation thereof

Info

Publication number
TW200716123A
TW200716123A TW095116637A TW95116637A TW200716123A TW 200716123 A TW200716123 A TW 200716123A TW 095116637 A TW095116637 A TW 095116637A TW 95116637 A TW95116637 A TW 95116637A TW 200716123 A TW200716123 A TW 200716123A
Authority
TW
Taiwan
Prior art keywords
preparation
methods
pteridines
hcv
hcv inhibitors
Prior art date
Application number
TW095116637A
Other languages
Chinese (zh)
Inventor
Pierre Jean-Marie Bernard Raboisson
Dominique Louis Nestor Ghislain Surleraux
Tse-I Lin
Oliver Lenz
Kenneth Alan Simmen
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of TW200716123A publication Critical patent/TW200716123A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents.
TW095116637A 2005-05-12 2006-05-11 Pteridines useful as HCV inhibitors and methods for the preparation thereof TW200716123A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68039305P 2005-05-12 2005-05-12
EP05106212 2005-07-07
EP06075854 2006-04-06

Publications (1)

Publication Number Publication Date
TW200716123A true TW200716123A (en) 2007-05-01

Family

ID=57911624

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116637A TW200716123A (en) 2005-05-12 2006-05-11 Pteridines useful as HCV inhibitors and methods for the preparation thereof

Country Status (1)

Country Link
TW (1) TW200716123A (en)

Similar Documents

Publication Publication Date Title
TW200716631A (en) Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
TW200626157A (en) HCV inhibiting bi-cyclic pyrimidines
WO2007026024A3 (en) Benzodiazepines as hcv inhibitors
EP2431379A3 (en) HCV inhibitors
SG151327A1 (en) Deazapurines useful as inhibitors of janus kinases
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
SG170828A1 (en) Deazapurines useful as inhibitors of janus kinases
UA100840C2 (en) Composition for the treatment of viral hepatitis
MXPA06011327A (en) Azaindoles useful as inhibitors of jak and other protein kinases.
UA95940C2 (en) Azaindoles useful as inhibitors of janus kinases
MY143795A (en) Tetrahydropyridoindole derivatives
TW200635596A (en) Pyridazinone compounds
MX2009013729A (en) Imidazopyrazines as protein kinase inhibitors.
MX2009004771A (en) Tricyclic heteroaryl compounds useful as inhibitors of janus kinase.
MX2009006345A (en) Compounds useful as protein kinase inhibitors.
WO2008040778A3 (en) Carboxamide 4-[(4-pyridyl)amino] pyrimidines for the treatment of hepatitis c
MY138708A (en) Biaryloxymethylarenecarboxylic acids
TN2009000398A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds
MX2009010127A (en) N-heterocyclic compounds useful as inhibitors of janus kinases.
TW200734334A (en) Treatment of substance abuse
WO2008073982A3 (en) 5,6-dihydro-1h-pyridin-2-one compounds
UA87494C2 (en) Azaindoles useful as inhibitors of jak and other protein kinases
MX2009010205A (en) P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease.
BRPI0606974A2 (en) use of iron complex compounds (iii)
CL2008003659A1 (en) Compounds derived from 6- (4-benzylpiperazin-1-yl) pyrimidin-4-one, modulators of the enzyme stearoyl-coa-desaturase 1; preparation procedure; pharmaceutical composition; and use in the treatment and prophylaxis of obesity.